American Journal of Nephrology data demonstrates KidneyIntelX successfully monitors patient response to SGLT2 therapy in 1,325 CANagliflozin CardioVAScular Assessment Study...
Enrollment complete in INTERGRIS-IPF Phase 2a clinical trial with top-line data expected mid-2022 FDA has authorized evaluation of long-term treatment...
Company on track to report three-month interim study results, including visual acuity, visual sensitivity, mobility and safety data, in Q2...
Forbes Technology Council, Invitation-Only Community for World-Class Technology Executives, Welcomes Dr. Saltman of Eko Eko Chief Medical Officer Dr. Adam...
Yumanity achieves research milestone in its collaboration with Merck; Yumanity to receive $5 million milestone payment Michael J. Fox Foundation...
Dana Brown and Timothy Norris Irish offer extensive experience in technology, women’s breast health and unique global perspectivesNASHUA, N.H., Jan....
OREM, Utah, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services...
+PlusCBD™ expands product offerings to include four new topicals that provide targeted pain relief +PlusCBD™ Pain Relief topicals +PlusCBD™ Pain...
Aramis Biosciences plans to initiate a Phase II clinical trial in Q1 2022BOSTON, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Aramis...
PHILADELPHIA, Jan. 11, 2022 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on the discovery...
Targets one of Healthcare’s Largest Multi-Billion Dollar Markets: Cardiac ElectrophysiologyTAMPA, Fla., Jan. 11, 2022 (GLOBE NEWSWIRE) -- H-CYTE, Inc. (OTCQB:...
PLEASANTON, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Healthcare Triangle Inc., (Nasdaq: HCTI) (“HCTI” or the "Company") a leading provider...
Dr. Ana Limón is a specialist in Oncology with extensive industry experienceTo coordinate global clinical strategy in oncology from Boston,...
miCAR Platform Enables Simultaneous Silencing of Multiple Gene TargetsAllogene to Deploy miCAR and other Technologies to Create the Next Generation...
Fourth quarter preliminary revenue of $38.0 to $38.3 million Full year 2021 preliminary revenue of $130.3 to $130.6 million Base...
ROCKAWAY, N.J., Jan. 11, 2022 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the...
SOUTH SAN FRANCISCO, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- Harpoon Therapeutics, Inc. (NASDAQ: HARP), a clinical-stage immunotherapy company developing...
BURBANK, Calif., Jan. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Medolife Rx, Inc. ("Medolife"), a global integrated biopharmaceutical company...
Updated data show a second partial response in Part B Overall response rate of 15.4% and disease control rate of...
Trial targeted to begin in the first quarter of 2022NRx is coordinating study with the US Health and Human Services...
